TRIM39 is a poor prognostic factor for patients with estrogen receptor‐positive breast cancer and promotes cell cycle progression
Tripartite motif (TRIM) family proteins are involved in various biological processes and the pathophysiology of cancers. However, the roles of TRIM39, a TRIM family member, in breast cancer is not well‐understood. Here, we performed immunohistochemical study of TRIM39 protein in clinical estrogen re...
Gespeichert in:
Veröffentlicht in: | Pathology international 2022-02, Vol.72 (2), p.96-106 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Tripartite motif (TRIM) family proteins are involved in various biological processes and the pathophysiology of cancers. However, the roles of TRIM39, a TRIM family member, in breast cancer is not well‐understood. Here, we performed immunohistochemical study of TRIM39 protein in clinical estrogen receptor‐positive (ER+) breast cancer tissues from 108 patients. TRIM39 immunoreactivity (IR) was positively correlated with advanced stage (p |
---|---|
ISSN: | 1320-5463 1440-1827 |
DOI: | 10.1111/pin.13190 |